BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17875870)

  • 21. [Eosinophilia--a challenging differential diagnosis].
    Seifert M; Gerth J; Gajda M; Pester F; Pfeifer R; Wolf G
    Med Klin (Munich); 2008 Aug; 103(8):591-7. PubMed ID: 18807233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infliximab: remicade].
    Bachelez H
    Ann Dermatol Venereol; 2007 Dec; 134(12):978-81. PubMed ID: 18166921
    [No Abstract]   [Full Text] [Related]  

  • 23. Cutaneous hypereosinophilia secondary to a low-grade B-cell lymphoma.
    Byrne N; Murphy A; O'Dwyer M
    Int J Dermatol; 2019 Aug; 58(8):e146-e147. PubMed ID: 31115899
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiopathic hypereosinophilic syndrome with multiple organ infarction: improvement of the skin condition masking the course of disease.
    Trattner H; Breier F; Steiner A; Wruhs M; Feldmann R
    Eur J Dermatol; 2014; 24(2):274-5. PubMed ID: 24667633
    [No Abstract]   [Full Text] [Related]  

  • 25. [Idiopathic hypereosinophilia syndrome and specific hepatitis. A case report].
    Lamarque P; Djossou F; Fach J; Malvy D; Lebail B; Longy-Boursier M; Le Bras M
    Rev Med Interne; 1998 Mar; 19(3):209-10. PubMed ID: 9775146
    [No Abstract]   [Full Text] [Related]  

  • 26. Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding.
    Balaskas K; Wyss P; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):437-8. PubMed ID: 22496024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypereosinophilic syndrome].
    Troelsen LN; Boisen LW; Andersen O
    Ugeskr Laeger; 2005 Dec; 167(49):4663-4. PubMed ID: 16336860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease.
    Niccoli L; Nannini C; Cassarà E; Gini G; Lenzetti I; Cantini F
    Br J Ophthalmol; 2009 Nov; 93(11):1553-4. PubMed ID: 19854741
    [No Abstract]   [Full Text] [Related]  

  • 29. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome.
    Sefcick A; Sowter D; DasGupta E; Russell NH; Byrne JL
    Br J Haematol; 2004 Feb; 124(4):558-9. PubMed ID: 14984510
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypereosinophilia associated with intrahepatic cholestasis in early infancy.
    Al-Binali AM; Al-Fifi SH; Al-Harthi AA; Al-Barki AA; Annobil SH
    Saudi Med J; 2000 Dec; 21(12):1182-4. PubMed ID: 11360096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic lobular panniculitis: remission induced and maintained with infliximab.
    Al-Niaimi F; Clark C; Thorrat A; Burden AD
    Br J Dermatol; 2009 Sep; 161(3):691-2. PubMed ID: 19519831
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypereosinophilic syndrome].
    Ishizuka T; Mori M
    Ryoikibetsu Shokogun Shirizu; 2000; (31):558-61. PubMed ID: 11269162
    [No Abstract]   [Full Text] [Related]  

  • 33. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y; Gaudio PA
    Ocul Immunol Inflamm; 2008; 16(4):167-71. PubMed ID: 18716952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.
    Looman KIM; Nuver ME; Korevaar TIM; Guillen SS
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33541953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypereosinophilic syndrome associated with systemic lupus erythematosus.
    Lee HJ; Yi JY; Kim TY; Kim CW
    Int J Dermatol; 1997 Feb; 36(2):152-3. PubMed ID: 9109019
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome?
    Offidani A; Bernardini ML; Simonetti O; Simoncini C; Giangiacomi M; Bossi G
    Br J Dermatol; 2000 Sep; 143(3):675-7. PubMed ID: 10971369
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.
    Olivieri I; Padula A; Leccese P; D'Angelo S; Giasi V
    J Rheumatol; 2009 Apr; 36(4):855. PubMed ID: 19342728
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibody and antibody-targeted therapy].
    Becker JC
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):703. PubMed ID: 16895576
    [No Abstract]   [Full Text] [Related]  

  • 39. Infliximab and Cogan's syndrome.
    Beccastrini E; Emmi G; Squatrito D; Vannucchi P; Emmi L
    Clin Otolaryngol; 2010 Oct; 35(5):441-2. PubMed ID: 21108761
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.
    Farruggia P; D'Angelo P; Acquaviva A; Trizzino A; Tucci F; Cilloni D; Messa F; D'Ambrosio A; Aricò M
    Pediatr Hematol Oncol; 2009; 26(3):129-35. PubMed ID: 19382034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.